pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-6769b |
Genomic Coordinates | chr1: 206474803 - 206474864 |
Description | Homo sapiens miR-6769b stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-6769b-3p | |||||||||||||||||||||||||||
Sequence | 42| CCCUCUCUGUCCCACCCAUAG |62 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Meta-analysis | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ADRB1 | ||||||||||||||||||||
Synonyms | ADRB1R, B1AR, BETA1AR, RHR | ||||||||||||||||||||
Description | adrenoceptor beta 1 | ||||||||||||||||||||
Transcript | NM_000684 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ADRB1 | |||||||||||||||||||||
3'UTR of ADRB1 (miRNA target sites are highlighted) |
>ADRB1|NM_000684|3'UTR 1 GGCCCGGCGCGGGGCGCGGACTCCGGGCACGGCTTCCCAGGGGAACGAGGAGATCTGTGTTTACTTAAGACCGATAGCAG 81 GTGAACTCGAAGCCCACAATCCTCGTCTGAATCATCCGAGGCAAAGAGAAAAGCCACGGACCGTTGCACAAAAAGGAAAG 161 TTTGGGAAGGGATGGGAGAGTGGCTTGCTGATGTTCCTTGTTGTTTTTTTTTTCTTTTCTTTTCTTTCTTCTTCTTTTTT 241 TTTTTTTTTTTTTTTTCTGTTTGTGGTCCGGCCTTCTTTTGTGTGTGCGTGTGATGCATCTTTAGATTTTTTTCCCCCAC 321 CAGGTGGTTTTTGACACTCTCTGAGAGGACCGGAGTGGAAGATGGGTGGGTTAGGGGAAGGGAGAAGCATTAGGAGGGGA 401 TTAAAATCGATCATCGTGGCTCCCATCCCTTTCCCGGGAACAGGAACACACTACCAGCCAGAGAGAGGAGAATGACAGTT 481 TGTCAAGACATATTTCCTTTTGCTTTCCAGAGAAATTTCATTTTAATTTCTAAGTAATGATTTCTGCTGTTATGAAAGCA 561 AAGAGAAAGGATGGAGGCAAAATAAAAAAAAATCACGTTTCAAGAAATGTTAAGCTCTTCTTGGAACAAGCCCCACCTTG 641 CTTTCCTTGTGTAGGGCAAACCCGCTGTCCCCCGCGCGCCTGGGTGGTCAGGCTGAGGGATTTCTACCTCACACTGTGCA 721 TTTGCACAGCAGATAGAAAGACTTGTTTATATTAAACAGCTTATTTATGTATCAATATTAGTTGGAAGGACCAGGCGCAG 801 AGCCTCTCTCTGTGACATGTGACTCTGTCAATTGAAGACAGGACATTAAAAGAGAGCGAGAGAGAGAAACAGTTCAGATT 881 ACTGCACATGTGGATAAAAACAAAAACAAAAAAAAGGAGTGGTTCAAAATGCCATTTTTGCACAGTGTTAGGAATTACAA 961 AATCCACAGAAGATGTTACTTGCACAAAAAGAAATTAAATATTTTTTAAAGGGAGAGGGGCTGGGCAGATCTTAAATAAA 1041 ATTCAAACTCTACTTCTGTTGTCTAGTATGTTATTGAGCTAATGATTCATTGGGAAAATACCTTTTTATACTCCTTTATC 1121 ATGGTACTGTAACTGTATCCATATTATAAATATAATTATCTTAAGGATTTTTTATTTTTTTTTATGTCCAAGTGCCCACG 1201 TGAATTTGCTGGTGAAAGTTAGCACTTGTGTGTAAATTCTACTTCCTCTTGTGTGTTTTACCAAGTATTTATACTCTGGT 1281 GCAACTAACTACTGTGTGAGGAATTGGTCCATGTGCAATAAATACCAATGAAGCACAATCAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545213. RNA binding protein: AGO2. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 153.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 153.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 153.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 5 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 6 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1
PAR-CLIP data was present in ERX177602. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_4
PAR-CLIP data was present in ERX177603. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_5
PAR-CLIP data was present in ERX177605. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_7
PAR-CLIP data was present in ERX177606. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_8
PAR-CLIP data was present in ERX177607. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_9
PAR-CLIP data was present in ERX177608. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_2_10
PAR-CLIP data was present in ERX177609. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_11
PAR-CLIP data was present in ERX177610. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_12
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
PAR-CLIP data was present in ERX177614. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_4
PAR-CLIP data was present in ERX177615. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_5
PAR-CLIP data was present in ERX177617. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_7
PAR-CLIP data was present in ERX177618. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_8
PAR-CLIP data was present in ERX177620. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_10
PAR-CLIP data was present in ERX177621. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_11
PAR-CLIP data was present in ERX177622. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_12
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
PAR-CLIP data was present in ERX177626. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_4
PAR-CLIP data was present in ERX177627. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_5
PAR-CLIP data was present in ERX177629. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_7
PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8
PAR-CLIP data was present in ERX177631. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_9
PAR-CLIP data was present in ERX177632. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_10
PAR-CLIP data was present in ERX177633. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_11
PAR-CLIP data was present in ERX177634. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_12
PAR-CLIP data was present in ERX177619. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_9
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
Experimental Support 7 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760632. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_C
PAR-CLIP data was present in SRX1760583. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_A
PAR-CLIP data was present in SRX1760591. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_B
PAR-CLIP data was present in SRX1760639. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP-MDV_A
PAR-CLIP data was present in SRX1760641. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP-MDV_B
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000369295.2 | 3UTR | CUGAGAGGACCGGAGUGGAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545213 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000369295.2 | 3UTR | CUGAGAGGACCGGAGUGGAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000369295.2 | 3UTR | CUGAGAGGACCGGAGUGGAAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000369295.2 | 3UTR | UCUGAGAGGACCGGAGUGGAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000369295.2 | 3UTR | UCUGAGAGGACCGGAGUGGAAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000369295.2 | 3UTR | UCUGAGAGGACCGGAGUGGAAGAUGGGUGGGUUAGGGGAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000369295.2 | 3UTR | UCUGAGAGGACCGGAGUGGAAGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000369295.2 | 3UTR | UCUGAGAGGACCGGAGUGGAAGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000369295.2 | 3UTR | UCUGAGAGGACCGGAGUGGAAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT181753 | UHMK1 | U2AF homology motif kinase 1 | 2 | 2 | ||||||||
MIRT287119 | SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | 2 | 2 | ||||||||
MIRT395372 | CDC42EP4 | CDC42 effector protein 4 | 2 | 4 | ||||||||
MIRT472533 | NACC1 | nucleus accumbens associated 1 | 2 | 4 | ||||||||
MIRT472611 | NAA50 | N(alpha)-acetyltransferase 50, NatE catalytic subunit | 2 | 2 | ||||||||
MIRT482405 | ADRB1 | adrenoceptor beta 1 | 2 | 10 | ||||||||
MIRT492330 | SETD1B | SET domain containing 1B | 2 | 2 | ||||||||
MIRT499238 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 6 | ||||||||
MIRT512274 | ARHGDIA | Rho GDP dissociation inhibitor alpha | 2 | 6 | ||||||||
MIRT534548 | RUNX1 | runt related transcription factor 1 | 2 | 2 | ||||||||
MIRT535374 | PEX5L | peroxisomal biogenesis factor 5 like | 2 | 2 | ||||||||
MIRT535424 | PDZD8 | PDZ domain containing 8 | 2 | 2 | ||||||||
MIRT539329 | AHSA2 | activator of HSP90 ATPase homolog 2 | 2 | 4 | ||||||||
MIRT569350 | EFHC1 | EF-hand domain containing 1 | 2 | 2 | ||||||||
MIRT576116 | Klf6 | Kruppel-like factor 6 | 2 | 2 | ||||||||
MIRT607241 | LINS | lines homolog 1 | 2 | 4 | ||||||||
MIRT607364 | ASAH2 | N-acylsphingosine amidohydrolase 2 | 2 | 4 | ||||||||
MIRT609572 | CATSPER4 | cation channel sperm associated 4 | 2 | 2 | ||||||||
MIRT610045 | SERPINA3 | serpin family A member 3 | 2 | 2 | ||||||||
MIRT610284 | PLCXD3 | phosphatidylinositol specific phospholipase C X domain containing 3 | 2 | 2 | ||||||||
MIRT610302 | KLHL21 | kelch like family member 21 | 2 | 2 | ||||||||
MIRT610393 | FOXE1 | forkhead box E1 | 2 | 2 | ||||||||
MIRT610432 | ASAH2B | N-acylsphingosine amidohydrolase 2B | 2 | 2 | ||||||||
MIRT610510 | BARHL2 | BarH like homeobox 2 | 2 | 2 | ||||||||
MIRT611818 | FCRL4 | Fc receptor like 4 | 2 | 2 | ||||||||
MIRT612755 | MYOCD | myocardin | 2 | 2 | ||||||||
MIRT613698 | QPRT | quinolinate phosphoribosyltransferase | 2 | 2 | ||||||||
MIRT613917 | POU3F1 | POU class 3 homeobox 1 | 2 | 2 | ||||||||
MIRT615153 | URGCP-MRPS24 | URGCP-MRPS24 readthrough | 2 | 2 | ||||||||
MIRT615201 | CLUAP1 | clusterin associated protein 1 | 2 | 2 | ||||||||
MIRT615338 | ABCC12 | ATP binding cassette subfamily C member 12 | 2 | 2 | ||||||||
MIRT616706 | UBXN2A | UBX domain protein 2A | 2 | 2 | ||||||||
MIRT617186 | GOSR2 | golgi SNAP receptor complex member 2 | 2 | 4 | ||||||||
MIRT617526 | SORCS2 | sortilin related VPS10 domain containing receptor 2 | 2 | 2 | ||||||||
MIRT617596 | NUDT5 | nudix hydrolase 5 | 2 | 4 | ||||||||
MIRT617763 | C17orf105 | chromosome 17 open reading frame 105 | 2 | 2 | ||||||||
MIRT618613 | SHOX | short stature homeobox | 2 | 2 | ||||||||
MIRT619301 | FAM26E | calcium homeostasis modulator family member 5 | 2 | 2 | ||||||||
MIRT619515 | TXLNB | taxilin beta | 2 | 2 | ||||||||
MIRT619925 | NLRP9 | NLR family pyrin domain containing 9 | 2 | 2 | ||||||||
MIRT619942 | C8orf33 | chromosome 8 open reading frame 33 | 2 | 2 | ||||||||
MIRT620025 | NFAM1 | NFAT activating protein with ITAM motif 1 | 2 | 2 | ||||||||
MIRT620554 | C10orf10 | chromosome 10 open reading frame 10 | 2 | 4 | ||||||||
MIRT620752 | CCR5 | C-C motif chemokine receptor 5 (gene/pseudogene) | 2 | 2 | ||||||||
MIRT621798 | TMEM233 | transmembrane protein 233 | 2 | 2 | ||||||||
MIRT621843 | TGFBR3 | transforming growth factor beta receptor 3 | 2 | 2 | ||||||||
MIRT622693 | PLSCR1 | phospholipid scramblase 1 | 2 | 2 | ||||||||
MIRT622733 | PITPNM3 | PITPNM family member 3 | 2 | 2 | ||||||||
MIRT623004 | ONECUT3 | one cut homeobox 3 | 2 | 2 | ||||||||
MIRT623211 | MTFR1L | mitochondrial fission regulator 1 like | 2 | 2 | ||||||||
MIRT623771 | GPR37L1 | G protein-coupled receptor 37 like 1 | 2 | 2 | ||||||||
MIRT624119 | DNAH10OS | dynein axonemal heavy chain 10 opposite strand | 2 | 2 | ||||||||
MIRT624150 | DIAPH1 | diaphanous related formin 1 | 2 | 2 | ||||||||
MIRT624443 | CAMK2N1 | calcium/calmodulin dependent protein kinase II inhibitor 1 | 2 | 2 | ||||||||
MIRT624855 | ABI2 | abl interactor 2 | 2 | 2 | ||||||||
MIRT625311 | SHISA6 | shisa family member 6 | 2 | 2 | ||||||||
MIRT625741 | MTSS1 | MTSS1, I-BAR domain containing | 2 | 2 | ||||||||
MIRT626292 | ZNF85 | zinc finger protein 85 | 2 | 2 | ||||||||
MIRT627400 | TMEM170A | transmembrane protein 170A | 2 | 2 | ||||||||
MIRT627464 | SYNRG | synergin gamma | 2 | 2 | ||||||||
MIRT627913 | KANSL1 | KAT8 regulatory NSL complex subunit 1 | 2 | 2 | ||||||||
MIRT636508 | GDAP1L1 | ganglioside induced differentiation associated protein 1 like 1 | 2 | 2 | ||||||||
MIRT636910 | KIAA0408 | KIAA0408 | 2 | 2 | ||||||||
MIRT637302 | ACTN2 | actinin alpha 2 | 2 | 2 | ||||||||
MIRT638230 | SOGA3 | SOGA family member 3 | 2 | 2 | ||||||||
MIRT639880 | STC1 | stanniocalcin 1 | 2 | 2 | ||||||||
MIRT639999 | PHF21B | PHD finger protein 21B | 2 | 2 | ||||||||
MIRT640149 | CEP104 | centrosomal protein 104 | 2 | 2 | ||||||||
MIRT640699 | SKI | SKI proto-oncogene | 2 | 2 | ||||||||
MIRT640911 | RAB13 | RAB13, member RAS oncogene family | 2 | 2 | ||||||||
MIRT641518 | CREBBP | CREB binding protein | 2 | 2 | ||||||||
MIRT641990 | OXSR1 | oxidative stress responsive 1 | 2 | 2 | ||||||||
MIRT642635 | EPPIN | epididymal peptidase inhibitor | 2 | 2 | ||||||||
MIRT642744 | TDRD6 | tudor domain containing 6 | 2 | 2 | ||||||||
MIRT642759 | SDHAF2 | succinate dehydrogenase complex assembly factor 2 | 2 | 2 | ||||||||
MIRT642787 | CHCHD3 | coiled-coil-helix-coiled-coil-helix domain containing 3 | 2 | 2 | ||||||||
MIRT643054 | EPPIN-WFDC6 | EPPIN-WFDC6 readthrough | 2 | 2 | ||||||||
MIRT643104 | NDUFB5 | NADH:ubiquinone oxidoreductase subunit B5 | 2 | 2 | ||||||||
MIRT643316 | TMEM151B | transmembrane protein 151B | 2 | 2 | ||||||||
MIRT643715 | ITK | IL2 inducible T-cell kinase | 2 | 2 | ||||||||
MIRT644087 | A4GALT | alpha 1,4-galactosyltransferase (P blood group) | 2 | 2 | ||||||||
MIRT644112 | SEL1L3 | SEL1L family member 3 | 2 | 2 | ||||||||
MIRT644377 | ZNF286A | zinc finger protein 286A | 2 | 2 | ||||||||
MIRT644408 | FRMD6 | FERM domain containing 6 | 2 | 2 | ||||||||
MIRT644684 | TMCO1 | transmembrane and coiled-coil domains 1 | 2 | 2 | ||||||||
MIRT644744 | CCDC174 | coiled-coil domain containing 174 | 2 | 2 | ||||||||
MIRT644876 | C2orf48 | chromosome 2 open reading frame 48 | 2 | 2 | ||||||||
MIRT645417 | FAM110A | family with sequence similarity 110 member A | 2 | 2 | ||||||||
MIRT645928 | PLXNA3 | plexin A3 | 2 | 2 | ||||||||
MIRT646181 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 2 | 2 | ||||||||
MIRT646554 | TMCC2 | transmembrane and coiled-coil domain family 2 | 2 | 2 | ||||||||
MIRT647235 | OR6A2 | olfactory receptor family 6 subfamily A member 2 | 2 | 2 | ||||||||
MIRT647263 | PTGDR2 | prostaglandin D2 receptor 2 | 2 | 2 | ||||||||
MIRT647660 | FOXL1 | forkhead box L1 | 2 | 2 | ||||||||
MIRT648284 | TRAPPC2L | trafficking protein particle complex 2 like | 2 | 2 | ||||||||
MIRT648493 | CMBL | carboxymethylenebutenolidase homolog | 2 | 2 | ||||||||
MIRT648963 | TMEM45B | transmembrane protein 45B | 2 | 2 | ||||||||
MIRT649511 | RAB17 | RAB17, member RAS oncogene family | 2 | 2 | ||||||||
MIRT650446 | CPXM2 | carboxypeptidase X, M14 family member 2 | 2 | 2 | ||||||||
MIRT650712 | KRT32 | keratin 32 | 2 | 2 | ||||||||
MIRT651069 | ZNF518B | zinc finger protein 518B | 2 | 4 | ||||||||
MIRT651090 | ZNF516 | zinc finger protein 516 | 2 | 2 | ||||||||
MIRT651193 | ZNF281 | zinc finger protein 281 | 2 | 2 | ||||||||
MIRT651330 | ZCCHC2 | zinc finger CCHC-type containing 2 | 2 | 2 | ||||||||
MIRT651445 | XKR4 | XK related 4 | 2 | 2 | ||||||||
MIRT651517 | WNT4 | Wnt family member 4 | 2 | 4 | ||||||||
MIRT651694 | VPS13D | vacuolar protein sorting 13 homolog D | 2 | 2 | ||||||||
MIRT652173 | TRIM66 | tripartite motif containing 66 | 2 | 2 | ||||||||
MIRT652432 | TMEM239 | transmembrane protein 239 | 2 | 2 | ||||||||
MIRT652656 | TIMM10 | translocase of inner mitochondrial membrane 10 | 2 | 2 | ||||||||
MIRT652707 | THBS2 | thrombospondin 2 | 2 | 2 | ||||||||
MIRT652812 | TBL2 | transducin beta like 2 | 2 | 2 | ||||||||
MIRT653350 | SMG7 | SMG7, nonsense mediated mRNA decay factor | 2 | 2 | ||||||||
MIRT653471 | SLC4A1 | solute carrier family 4 member 1 (Diego blood group) | 2 | 2 | ||||||||
MIRT653658 | SLC27A4 | solute carrier family 27 member 4 | 2 | 2 | ||||||||
MIRT654691 | PSMB5 | proteasome subunit beta 5 | 2 | 2 | ||||||||
MIRT654735 | PRLR | prolactin receptor | 2 | 2 | ||||||||
MIRT654931 | POLR3D | RNA polymerase III subunit D | 2 | 2 | ||||||||
MIRT655209 | PHAX | phosphorylated adaptor for RNA export | 2 | 2 | ||||||||
MIRT655346 | PCP4L1 | Purkinje cell protein 4 like 1 | 2 | 2 | ||||||||
MIRT655404 | PANK1 | pantothenate kinase 1 | 2 | 2 | ||||||||
MIRT655482 | PAK3 | p21 (RAC1) activated kinase 3 | 2 | 2 | ||||||||
MIRT655964 | NDNF | neuron derived neurotrophic factor | 2 | 2 | ||||||||
MIRT656017 | MYPN | myopalladin | 2 | 2 | ||||||||
MIRT656491 | MAP3K9 | mitogen-activated protein kinase kinase kinase 9 | 2 | 2 | ||||||||
MIRT657151 | ITGA1 | integrin subunit alpha 1 | 2 | 2 | ||||||||
MIRT657411 | HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 | 2 | 2 | ||||||||
MIRT657608 | GRID1 | glutamate ionotropic receptor delta type subunit 1 | 2 | 2 | ||||||||
MIRT658181 | FBXO9 | F-box protein 9 | 2 | 2 | ||||||||
MIRT658932 | DPY19L1 | dpy-19 like C-mannosyltransferase 1 | 2 | 2 | ||||||||
MIRT659028 | DHTKD1 | dehydrogenase E1 and transketolase domain containing 1 | 2 | 2 | ||||||||
MIRT659092 | DENR | density regulated re-initiation and release factor | 2 | 2 | ||||||||
MIRT659204 | CYBB | cytochrome b-245 beta chain | 2 | 2 | ||||||||
MIRT659718 | CCDC93 | coiled-coil domain containing 93 | 2 | 2 | ||||||||
MIRT660185 | BNC2 | basonuclin 2 | 2 | 2 | ||||||||
MIRT660805 | AIFM2 | apoptosis inducing factor, mitochondria associated 2 | 2 | 2 | ||||||||
MIRT660900 | ADCY6 | adenylate cyclase 6 | 2 | 2 | ||||||||
MIRT660925 | ADAM19 | ADAM metallopeptidase domain 19 | 2 | 2 | ||||||||
MIRT661741 | DTHD1 | death domain containing 1 | 2 | 2 | ||||||||
MIRT661998 | EFTUD2 | elongation factor Tu GTP binding domain containing 2 | 2 | 2 | ||||||||
MIRT662639 | PKHD1L1 | PKHD1 like 1 | 2 | 2 | ||||||||
MIRT664338 | RAB8A | RAB8A, member RAS oncogene family | 2 | 2 | ||||||||
MIRT666743 | RALY | RALY heterogeneous nuclear ribonucleoprotein | 2 | 2 | ||||||||
MIRT667070 | PANK3 | pantothenate kinase 3 | 2 | 2 | ||||||||
MIRT667925 | IGLON5 | IgLON family member 5 | 2 | 2 | ||||||||
MIRT668488 | ETV3 | ETS variant 3 | 2 | 2 | ||||||||
MIRT668610 | EHD4 | EH domain containing 4 | 2 | 2 | ||||||||
MIRT669419 | ATP9A | ATPase phospholipid transporting 9A (putative) | 2 | 2 | ||||||||
MIRT669652 | ACSBG1 | acyl-CoA synthetase bubblegum family member 1 | 2 | 2 | ||||||||
MIRT674005 | KCNN3 | potassium calcium-activated channel subfamily N member 3 | 2 | 2 | ||||||||
MIRT680447 | SLCO5A1 | solute carrier organic anion transporter family member 5A1 | 2 | 2 | ||||||||
MIRT684326 | GTF3C4 | general transcription factor IIIC subunit 4 | 2 | 2 | ||||||||
MIRT685625 | C12orf49 | chromosome 12 open reading frame 49 | 2 | 2 | ||||||||
MIRT689978 | ZNF185 | zinc finger protein 185 with LIM domain | 2 | 2 | ||||||||
MIRT693962 | HNRNPA1L2 | heterogeneous nuclear ribonucleoprotein A1-like 2 | 2 | 2 | ||||||||
MIRT698543 | TFRC | transferrin receptor | 2 | 2 | ||||||||
MIRT699982 | RREB1 | ras responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT702898 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 2 | 2 | ||||||||
MIRT707383 | VCAM1 | vascular cell adhesion molecule 1 | 2 | 2 | ||||||||
MIRT708312 | CDH8 | cadherin 8 | 2 | 2 | ||||||||
MIRT708406 | GRIN2A | glutamate ionotropic receptor NMDA type subunit 2A | 2 | 2 | ||||||||
MIRT709299 | LDLRAD4 | low density lipoprotein receptor class A domain containing 4 | 2 | 2 | ||||||||
MIRT710326 | STK40 | serine/threonine kinase 40 | 2 | 2 | ||||||||
MIRT710729 | C19orf68 | zinc finger SWIM-type containing 9 | 2 | 2 | ||||||||
MIRT710970 | CMKLR1 | chemerin chemokine-like receptor 1 | 2 | 2 | ||||||||
MIRT711178 | EMCN | endomucin | 2 | 2 | ||||||||
MIRT711590 | SETD1A | SET domain containing 1A | 2 | 2 | ||||||||
MIRT711611 | LHX5 | LIM homeobox 5 | 2 | 2 | ||||||||
MIRT711701 | GMPR | guanosine monophosphate reductase | 2 | 2 | ||||||||
MIRT711850 | AMOTL2 | angiomotin like 2 | 2 | 2 | ||||||||
MIRT712358 | NAT14 | N-acetyltransferase 14 (putative) | 2 | 2 | ||||||||
MIRT712377 | MTPN | myotrophin | 2 | 2 | ||||||||
MIRT712469 | KCNC3 | potassium voltage-gated channel subfamily C member 3 | 2 | 2 | ||||||||
MIRT712839 | RHOA | ras homolog family member A | 2 | 2 | ||||||||
MIRT713592 | ANKMY1 | ankyrin repeat and MYND domain containing 1 | 2 | 2 | ||||||||
MIRT713982 | ASIC4 | acid sensing ion channel subunit family member 4 | 2 | 2 | ||||||||
MIRT714534 | ZBTB39 | zinc finger and BTB domain containing 39 | 2 | 2 | ||||||||
MIRT714570 | GALNT10 | polypeptide N-acetylgalactosaminyltransferase 10 | 2 | 2 | ||||||||
MIRT714610 | EXO5 | exonuclease 5 | 2 | 2 | ||||||||
MIRT714943 | ZNF330 | zinc finger protein 330 | 2 | 2 | ||||||||
MIRT715132 | ACADL | acyl-CoA dehydrogenase, long chain | 2 | 2 | ||||||||
MIRT716018 | TMPRSS5 | transmembrane protease, serine 5 | 2 | 2 | ||||||||
MIRT716204 | TYW3 | tRNA-yW synthesizing protein 3 homolog | 2 | 2 | ||||||||
MIRT716674 | PPP6R1 | protein phosphatase 6 regulatory subunit 1 | 2 | 2 | ||||||||
MIRT717366 | EDN2 | endothelin 2 | 2 | 2 | ||||||||
MIRT718110 | CRTC1 | CREB regulated transcription coactivator 1 | 2 | 2 | ||||||||
MIRT718502 | GYS1 | glycogen synthase 1 | 2 | 2 | ||||||||
MIRT719146 | DPYSL5 | dihydropyrimidinase like 5 | 2 | 2 | ||||||||
MIRT719415 | B4GALNT3 | beta-1,4-N-acetyl-galactosaminyltransferase 3 | 2 | 2 | ||||||||
MIRT719986 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 2 | ||||||||
MIRT720347 | BACE2 | beta-site APP-cleaving enzyme 2 | 2 | 2 | ||||||||
MIRT720452 | SLC16A5 | solute carrier family 16 member 5 | 2 | 2 | ||||||||
MIRT720493 | TMEM178B | transmembrane protein 178B | 2 | 2 | ||||||||
MIRT720666 | C11orf54 | chromosome 11 open reading frame 54 | 2 | 2 | ||||||||
MIRT721091 | CCBE1 | collagen and calcium binding EGF domains 1 | 2 | 2 | ||||||||
MIRT721334 | IFNAR2 | interferon alpha and beta receptor subunit 2 | 2 | 2 | ||||||||
MIRT721384 | MACC1 | MACC1, MET transcriptional regulator | 2 | 2 | ||||||||
MIRT721508 | CARHSP1 | calcium regulated heat stable protein 1 | 2 | 2 | ||||||||
MIRT721827 | POU6F1 | POU class 6 homeobox 1 | 2 | 2 | ||||||||
MIRT722136 | TTLL11 | tubulin tyrosine ligase like 11 | 2 | 2 | ||||||||
MIRT723070 | GGA1 | golgi associated, gamma adaptin ear containing, ARF binding protein 1 | 2 | 2 | ||||||||
MIRT723115 | ZSCAN16 | zinc finger and SCAN domain containing 16 | 2 | 2 | ||||||||
MIRT723374 | ZNF470 | zinc finger protein 470 | 2 | 2 | ||||||||
MIRT724446 | OPA3 | OPA3, outer mitochondrial membrane lipid metabolism regulator | 2 | 2 | ||||||||
MIRT724528 | ATP2B1 | ATPase plasma membrane Ca2+ transporting 1 | 2 | 2 | ||||||||
MIRT724643 | PKDREJ | polycystin family receptor for egg jelly | 2 | 2 | ||||||||
MIRT724711 | CRAMP1L | cramped chromatin regulator homolog 1 | 2 | 2 | ||||||||
MIRT724750 | ZNF391 | zinc finger protein 391 | 2 | 2 | ||||||||
MIRT724770 | PSG4 | pregnancy specific beta-1-glycoprotein 4 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|